Table 2. Identity and Significance of 10 PD vs. Control Diagnostic Biomarkers.
| Database ID | Description | Prevalence in PD | Prevalence in Controls | p |
| NM_001544.2 | Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) (ICAM4), transcript variant 1 | 93.55% | 2.38% | 1.73E-18 |
| NM_024754.2 | Pentatricopeptide repeat domain 2 (PTCD2) | 90.32% | 7.14% | 9.40E-13 |
| BC051695.1 | FERM domain containing 8 (FRMD8) | 87.10% | 4.76% | 1.31E-14 |
| PHR5001 | Recombinant human CTLA-4/Fc | 87.10% | 14.29% | 6.14E-11 |
| NM_006790.1 | Myotilin (MYOT) | 90.32% | 21.43% | 5.66E-10 |
| NM_032855.1 | Hematopoietic SH2 domain containing (HSH2D) | 87.10% | 7.14% | 1.71E-13 |
| BC005858.1 | Fibronectin 1 (FN1) | 90.32% | 14.29% | 7.39E-08 |
| NM_003141.2 | Tripartite motif-containing 21 (TRIM21) | 80.65% | 9.52% | 1.07E-10 |
| BC094687.1 | Elongation factor 1-alpha 1 | 87.10% | 7.14% | 3.03E-10 |
| BC027617.1 | Poly(A) binding protein, cytoplasmic 3 (PABPC3) | 74.19% | 11.91% | 0.000805 |